IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q1 2023 Holdings

Filed 2023-05-15 | 8 holdings | $279.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-05-16) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Amryt Pharma PLCASponsored ADS03217L106$129.1M8,857,26846.3%
Biora Inc.ANote 7.250% 12/074319FAB3$58.1M$103,500,00020.8%
Omeros CorpANOTE 5.250% 2/1682143AG7$46.5M$65,136,00016.7%
RVL Pharmaceuticals PLCASHSG6S41R101$16.6M14,600,4446.0%
Omeros CorpANOTE 6.250%11/1682143AE2$11.1M$11,005,0004.0%
Paratek Pharmaceuticals Inc.ANOTE 4.750% 5/0699374AB0$7.4M$9,000,0002.7%
Puma Biotechnology Inc(PBYI)ACOM74587V107$5.5M1,792,1142.0%
Biora Inc.ACOM74319F305$4.7M1,694,4811.7%